AZ to settle US marketing case Health / Medicine Related News
AstraZeneca is poised to pay more than $500m to settle allegations in the US of marketing abuses of its second-most important drug Source: FT.com - Pharmaceuticals
I hope that this case send a clear message to other drug makers that we here in the US are not going to accept other uses for a medicine that has not been proven to help.
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,